BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 32141182)

  • 1. High-dose folic acid and its effect on early stage diabetic foot ulcer wound healing.
    Boykin JV; Hoke GD; Driscoll CR; Dharmaraj BS
    Wound Repair Regen; 2020 Jul; 28(4):517-525. PubMed ID: 32141182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial of Integra Template for diabetic foot ulcer treatment.
    Driver VR; Lavery LA; Reyzelman AM; Dutra TG; Dove CR; Kotsis SV; Kim HM; Chung KC
    Wound Repair Regen; 2015; 23(6):891-900. PubMed ID: 26297933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR; Reyzelman A; Kawalec J; French M
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective, Descriptive Study to Assess the Clinical Benefits of Using Calendula officinalis Hydroglycolic Extract for the Topical Treatment of Diabetic Foot Ulcers.
    Buzzi M; de Freitas F; Winter M
    Ostomy Wound Manage; 2016 Mar; 62(3):8-24. PubMed ID: 26978856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human placental membrane as a wound cover for chronic diabetic foot ulcers: a prospective, postmarket, CLOSURE study.
    Pacaccio DJ; Cazzell SM; Halperin GJ; Kasper MA; Neutel JM; O'Carroll BD; Reyzelman AM
    J Wound Care; 2018 Jul; 27(Sup7):S28-S37. PubMed ID: 30008251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Erythropoietin Accelerates Wound Closure in Patients with Diabetic Foot Ulcers: A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial.
    Hamed S; Ullmann Y; Belokopytov M; Shoufani A; Kabha H; Masri S; Feldbrin Z; Kogan L; Kruchevsky D; Najjar R; Liu PY; Kerihuel JC; Akita S; Teot L
    Rejuvenation Res; 2021 Aug; 24(4):251-261. PubMed ID: 33504262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicinal Plants as Efficacious Agents for Diabetic Foot Ulcers: A Systematic Review of Clinical Studies.
    Ahmadian R; Bahramsoltani R; Marques AM; Rahimi R; Farzaei MH
    Wounds; 2021 Aug; 33(8):207-218. PubMed ID: 34357879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors for developing infection in patients presenting with uninfected diabetic foot ulcers.
    Jia L; Parker CN; Parker TJ; Kinnear EM; Derhy PH; Alvarado AM; Huygens F; Lazzarini PA;
    PLoS One; 2017; 12(5):e0177916. PubMed ID: 28545120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of maggot debridement therapy in promoting wound angiogenesis in patients with diabetic foot ulcer].
    Wang TY; Chen YC; Wang W; Jiang D; Liu L; Yang H; Wang AP
    Zhonghua Shao Shang Za Zhi; 2020 Nov; 36(11):1040-1049. PubMed ID: 33238687
    [No Abstract]   [Full Text] [Related]  

  • 11. Negative-pressure wound therapy for management of chronic neuropathic noninfected diabetic foot ulcerations - short-term efficacy and long-term outcomes.
    Borys S; Hohendorff J; Koblik T; Witek P; Ludwig-Slomczynska AH; Frankfurter C; Kiec-Wilk B; Malecki MT
    Endocrine; 2018 Dec; 62(3):611-616. PubMed ID: 30099674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Nonhealing Diabetic Foot Wounds with Vaporous Hyperoxia Therapy in Conjunction with Standard Wound Care.
    Kruse D; Morgan K; Christensen J; Derner BS; Sachs B
    J Am Podiatr Med Assoc; 2023; 113(2):. PubMed ID: 34473280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward Developing Immunocompetent Diabetic Foot Ulcer-on-a-Chip Models for Drug Testing.
    Ejiugwo M; Rochev Y; Gethin G; O'Connor G
    Tissue Eng Part C Methods; 2021 Feb; 27(2):77-88. PubMed ID: 33406980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of TLR9 associated with pro-inflammatory S100A8 and IL-8 in diabetic wounds could lead to unresolved inflammation in type 2 diabetes mellitus (T2DM) cases with impaired wound healing.
    Singh K; Agrawal NK; Gupta SK; Sinha P; Singh K
    J Diabetes Complications; 2016; 30(1):99-108. PubMed ID: 26525587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Wound Closure Rates Using a Human Fibroblast-derived Dermal Substitute Versus a Fetal Bovine Collagen Dressing: A Retrospective Study.
    Fitzgerald RH; Sabolinski ML; Skornicki M
    Wound Manag Prev; 2019 Sep; 65(9):26-34. PubMed ID: 31702990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker Prediction of Postoperative Healing of Diabetic Foot Ulcers: A Retrospective Observational Study of Serum Albumin.
    Cheng P; Dong Y; Hu Z; Huang S; Cao X; Wang P; Xu H; Zhu J; Tang B
    J Wound Ostomy Continence Nurs; 2021 Jul-Aug 01; 48(4):339-344. PubMed ID: 34186553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-rich plasma for the treatment of diabetic foot ulcer: a systematic review.
    OuYang H; Tang Y; Yang F; Ren X; Yang J; Cao H; Yin Y
    Front Endocrinol (Lausanne); 2023; 14():1256081. PubMed ID: 38169990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of characteristics and healing course of diabetic foot ulcers by etiological classification: neuropathic, ischemic, and neuro-ischemic type.
    Yotsu RR; Pham NM; Oe M; Nagase T; Sanada H; Hara H; Fukuda S; Fujitani J; Yamamoto-Honda R; Kajio H; Noda M; Tamaki T
    J Diabetes Complications; 2014; 28(4):528-35. PubMed ID: 24846054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of differential microbiomes in healing versus non-healing diabetic foot ulcers prior to and following foot salvage therapy.
    MacDonald A; Brodell JD; Daiss JL; Schwarz EM; Oh I
    J Orthop Res; 2019 Jul; 37(7):1596-1603. PubMed ID: 30908702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
    Kaur R; Tchanque-Fossuo C; West K; Hadian Y; Gallegos A; Yoon D; Ismailyan L; Schaefer S; Dahle SE; Isseroff RR
    Trials; 2020 Jun; 21(1):496. PubMed ID: 32513257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.